Program Co-Chairs
Christopher Leung, MD
Hong Kong, PR China
Professor Christopher Leung is a clinician-scientist with research focus in glaucoma detection and diagnostic imaging of the optic nerve. He read a MSc in Molecular Medicine at Imperial College London and obtained his medical training (MB ChB) and doctoral education (MD) from the Chinese University of Hong Kong (CUHK). Awarded with the Croucher Foundation Fellowship, he completed a clinical and research fellowship at the Hamilton Glaucoma Center, the University of California, San Diego (UCSD). The research team led by Dr. Leung has been playing a leading role in introducing key concepts and new technologies for early diagnosis of glaucoma and detection of its progression. His research group also investigates new treatment strategies for neuroprotection and neuroregeneration in glaucoma and optic neuropathies.
Shan Lin, MD
San Francisco, CA, USA
Dr. Lin is Co-Director of Research at the Glaucoma Center of San Francisco. He graduated from UC Berkeley for his undergraduate education and achieved his medical degree at Tufts Medical School. His internship, ophthalmology residency, and glaucoma fellowship were completed at the University of California, San Francisco. He is the former Director of the Glaucoma Service and Professor of Ophthalmology at UCSF.
He is an author on over 250 peer-reviewed publications. His areas of research interest include angle-closure glaucoma, anterior segment imaging, and cyclodestructive procedures. He is immediate past-Executive Vice President of the World Glaucoma Association. His past leadership positions include Chair of the American Glaucoma Society’s Patient Care Committee, Chair of the Glaucoma Section of the Ophthalmic Technology Assessment Committee of the American Academy of Ophthalmology, Chair of the American Glaucoma Society’s Document Review Subcommittee, and President, Vice President and Program Chair of the Pacific Coast Oto-Ophthalmological Society (PCOOS).
His past honors include the Heed Fellowship Award, the American Glaucoma Society Clinician-Scientist Award, and the Mid-Career Award by the AGS. He has also been funded as a Principal Investigator by the National Institute of Health, including as a PI for the Ocular Hypertension Treatment Study (OHTS) study. He has been selected for “Best Doctors” in the U.S. He is currently on the editorial boards for the American Journal of Ophthalmology and Journal of Glaucoma.